Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
VJ8vLkY4Tc4ekuyh